ESC 365 - Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

HFA Premium Access

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Session: Late breaking trial IV - Registries

Topic: Biomarkers

Speaker: Professor D. Kotecha (Birmingham, GB)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

42 presentations

9 followers

11 more presentations in this session

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Speaker: Doctor Y. Khariton (Kansas City, US)

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Discussion - ARM-CAD

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Speaker: Professor K. Branch (Seattle, US)

Discussion - COMPASS CHF

Access the full session

Late breaking trial IV - Registries

Speakers: Professor D. Kotecha, Doctor Y. Khariton, Professor K. Branch

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources